HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹72 Cr | ₹128 Cr | ₹24 Cr | ₹80 Cr | ₹78 Cr |
What is the latest Long Term Provisions ratio of HIKAL ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹78 Cr |
How is Long Term Provisions of HIKAL Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | -44.07 | |
| Mar2024 | ₹128 Cr | 429.23 | |
| Mar2023 | ₹24 Cr | -69.56 | |
| Mar2022 | ₹80 Cr | 2.11 | |
| Mar2021 | ₹78 Cr | - | |
Compare Long Term Provisions of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,774.9 Cr | -6.9% | 9.7% | -33.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -6.9% |
9.7% |
-33.6% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses